Philips Recalled CPAP/Bi-Level PAP Litigation Update: Federal Cases Centralized in MDL in Western District of Pennsylvania

Categories: Philips CPAP and BiPAP Recall

Philips Recalled CPAP/Bi-Level PAP Litigation Update: Federal Cases Centralized in MDL in Western District of Pennsylvania

On October 8, 2021, the Judicial Panel on Multidistrict Litigation (“JPML”) created a new MDL (“multidistrict litigation”) for federal lawsuits for individuals who have suffered due to Philips’ recalled Continuous Positive Airway Pressure (CPAP), Bi-Level Positive Airway Pressure (Bi-Level PAP), and mechanical ventilator devices, which contain polyester-based polyurethane (PE-PUR) sound abatement foam that may degrade...

Read More

HOMEOWNERS AND LIFE INSURANCE CLAIM DISPUTES & DENIALS

Categories: Insurance Claim Denials

Couple with Denied Claim

Combating Denied Homeowners & Life/Accidental Death Insurance Claims The main reason you buy homeowners insurance is to cover the cost of damage to your house and property. For this reason, you naturally expect the insurance company to cooperate and cover the costs after a hailstorm, fire or other disaster. Similarly, you purchase life or accidental...

Read More

Lawsuits Filed By Paraquat Herbicide Users Who Have Developed Parkinson’s Disease

Categories: Uncategorized

What is Paraquat? Paraquat dichloride (commonly referred to as “paraquat”) is a toxic chemical that is widely used as an herbicide (plant killer), primarily for weed and grass control. It is marked under various brand names including Gramoxone, Cyclone, Helmquat, Parazone, Firestorm, and others. In the United States, paraquat is available primarily as a liquid...

Read More

BREAKING NEWS REGARDING ELMIRON® LAWSUITS: Federal Lawsuits for Vision Problems Centralized in N.J. Federal Court

Categories: Elmiron Lawsuits for Vision Problems

Yesterday, the Judicial Panel on Multidistrict Litigation (JPML) created a new MDL for federal lawsuits for individuals who have developed a serious vision disorder called pigmentary maculopathy after taking Elmiron®. The lawsuits allege that the drugmakers failed to properly warn consumers, physicians, and the public that Elmiron® could cause significant visual damage, including atypical or pigmentary...

Read More

EXPANDED RECALL OF POPULAR DIABETES DRUG DUE TO HIGH LEVELS OF CANCER-CAUSING AGENT

Categories: Metformin Recall

Additional lots of the widely-used diabetes drug, metformin hydrochloride, have been recalled after they were found to contain unacceptably high levels of a cancer-causing contaminant. Marksans Pharma Limited, India has voluntarily expanded its earlier initiated recall on June 05, 2020 to include an additional 76 unexpired lots of Metformin Hydrochloride Extended-Release Tablets, USP 500mg, &...

Read More

TENOFOVIR LAWSUITS RELATED TO KIDNEY & BONE INJURIES

Categories: Pharmaceutical litigation

What You Should Know: Tenofovir Disoproxil Fumarate (“TDF” or “tenofovir DF”) is a prescription drug that is used to treat HIV infection and chronic hepatitis B virus infections in certain patients. The brand name for TDF is VIREAD®. TDF is also used in combination drug prescriptions, including Truvada®, Atripla®, Complera® and Stribild®. Lawsuits have been filed...

Read More

ELMIRON® LAWSUITS FOR VISION PROBLEMS

Categories: Elmiron Lawsuits for Vision Problems

What You Should Know: Elmiron®, a prescription drug used to treat bladder pain or discomfort from interstitial cystitis, has been linked to a serious vision disorder called pigmentary maculopathy. This condition resulting from Elmiron® use can be confused with or initially diagnosed as age-related macular degeneration, macular or pattern dystrophy, diabetic retinopathy, or certain other...

Read More